skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine (Code C2620)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine

Definition: A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). This agent may enhance CEA presentation to antigen presenting cells (APC) and activate cytotoxic T-cells against CEA-expressing tumors. (NCI04)

Display Name: Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine

Label: Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine

NCI Thesaurus Code: C2620 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0935790  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
Recombinant Fowlpox-CEA-TRICOM Vaccine

External Source Codes: 
NSC Code 710068 (see NCI DTP info)
PDQ Closed Trial Search ID 38216
PDQ Open Trial Search ID 38216 (check for NCI PDQ open clinical trial info)
UMLS CUI C0935790

Other Properties:
     Name Value (qualifiers indented underneath)
code C2620
Contributing_Source CTRP
Legacy_Concept_Name Fowlpox-CEA-TRICOM_Vaccine
Semantic_Type Pharmacologic Substance
Semantic_Type Virus

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom